@article{Koç_Kapucu_Kıratlı_2023, title={Clinical Features and Treatment Results of Conjunctival Melanoma: Cross-Sectional Study}, volume={54}, url={https://actamedica.org/index.php/actamedica/article/view/877}, DOI={10.32552/2023.ActaMedica.877}, abstractNote={<p><strong>Purpose:</strong> Our aim in this study is to report the clinical features and treatment results of patients with conjunctival melanoma (CM) diagnosed in our clinic in the last 20 years.</p> <p><strong>Materials and Methods:</strong> Demographic information, tumor diameter, accompanying melanosis, presence of recurrence and survival data were obtained retrospectively from the records of patients who had histopathologically confirmed CM diagnosis.</p> <p><strong>Results:</strong> Conjunctival melanoma was detected in 84 eyes of 84 patients with a mean age of 61.5±24.6 years. In total 45.2% of the patients were female and 54.8% were male. The two most common primary lesion locations were limbus in 23.8% and bulbar conjunctiva in 22.6% of the patients. In ophthalmological evaluation, 46.3% of the patients had concomitant primary acquired melanosis. Appropriate surgical excision to the extent of the disease was performed primarily in all patients. After a median follow-up of 55 months, local recurrence rate was 45.2%, while the survival rate was found to be 74.3%.</p> <p><strong>Conclusion:</strong> Conjunctival melanoma is a malignant neoplasm seen in advanced adulthood, often involving the bulbar surface of the conjunctiva. Even using the standard surgical approach, CM is associated with a 45.2% local recurrence rate and a 25.7% mortality rate. In our study, there was no clinical parameter that showed a statistically significant relationship with survival.</p>}, number={1}, journal={Acta Medica}, author={Koç, İrem and Kapucu, Yasemin and Kıratlı, Hayyam}, year={2023}, month={Mar.}, pages={54–58} }